Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFRODITE: Dronedarone Added to vs. Intensified Conventional Rate Control in Atrial Fibrillation
2009-018215-53Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dronedarone in Atrial fibrillation (AFib) (2 arms), sponsored by Sanofi. Primary endpoint: Ventricular rate after 1 week. Started Dec 2009; status: terminated.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2009-018215-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018215-53.